CVS vs NTLA · P/E 16, rev $402.07B vs rev $57.9M
CVS Health Corp (CVS) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the CVS and NTLA stock pages for the full models.
Not investment advice.